Your clinicians are signing AI-drafted notes. We tell you what those notes are getting wrong.
Your EHR vendor has not published hallucination rate, error type, severity, or risk disclosure for the summary and scribe features your hospital is running. Idem Labs audits what is actually happening in your environment, addressed to your AI governance committee.
The AI in your medical record is not silent. It is unverified.
If your hospital runs Epic Art, Oracle Health Clinical AI Agent, or Meditech Expanse summarization, your patient charts are being summarized by AI today. Discharge summaries are being auto-drafted. In-basket messages are being summarized and pre-replied. The attending physician signs.
Your informatics team does not have a structured methodology to produce an audit-defensible answer on what the AI is doing. Big 4 governance work delivers a framework, not a finding against the AI you actually have running.
In May 2026, Ontario's Auditor General audited all 20 AI scribes approved for clinical use in the province. All had inaccuracies. The clinical-to-legal translation for a US hospital is direct: a transposed medication in an AI-drafted discharge note, signed by an exhausted hospitalist, no audit trail distinguishing AI from clinician edits, no Applied Model Card on file. Malpractice and False Claims Act discovery walks right in.
A 6-8 week post-deployment audit. Signed dossier at the end.
Three components carry the audit. Black-box performance and equity testing against a clinician-validated reference panel built on de-identified or synthetic records from your environment. HTI-1 source-attribute compliance and audit-trail review confirming the AI model and version are preserved in the legal record. A 25-40 page written risk inventory signed by Idem Labs and addressed to your AI governance committee.
Contract and indemnification review, malpractice carrier alignment check, and prioritized remediation planning are included. Full component detail lives on the Post-Deployment Audit service page.
The engagement letter is signed by your hospital, not the EHR vendor. The dossier is your property.
Who it is for
CMIOs, Chief AI Officers, CMOs, Chief Compliance Officers, and Chief Risk Officers at academic medical centers and sophisticated community systems with 500+ beds. Best fit when at least one EHR-native AI summary feature has been live in production for six or more months and a recent leadership conversation has surfaced AI as a board, GC, or malpractice question.
Read the evidence.
Then let's talk.
The June 2026 white paper documents what EHR-native AI features are doing in the medical record and what your organization is on the hook for.